The Power of Collaboration: Beyond Blood
A Budding Entrepreneur, an Engaged Rare Disease Community, and a Transformative New Device.
Have you or someone you care for with a rare condition needed blood tests recently? Now, imagine a world where checking your health is as simple as making a cup of tea—no hospital visits, no waiting rooms, and no needles. This is the future Beyond Blood Diagnostics is creating.
Founded in 2022 by Manfredi San Germano, Beyond Blood Diagnostics is developing a revolutionary at-home blood-testing device that could redefine healthcare, especially for those living with chronic and rare conditions. This device promises to be portable, easy to use, pain-free, and quick, delivering reliable blood test results in less than 15 minutes—all from a simple finger prick. The team’s patented technology harnesses cutting-edge AI and microfluidic chips, allowing users to get a full blood count (FBC) at home, providing insights that could diagnose infections, neutropenia, anaemia, and more.
Beyond Blood’s journey from an innovative idea to a promising tech solution is one powered by community engagement, particularly with the rare disease community. The rare disease community’s role in shaping and guiding this product has been instrumental. And now, this exciting partnership is headed to RAREfest24, where Beyond Blood will showcase its prototype—a true testament to the power of collaboration and consultation.
Beyond Blood: A Vision to Revolutionise At-Home Blood Testing
Manfredi San Germano is no stranger to life sciences innovation. With a background in commercialising genomic tests and a PhD in Biomedical Engineering from Imperial College London, Manfredi’s expertise in microfluidic applications in medicine set the stage for Beyond Blood’s inception. His belief? The next frontier of patient care lies in empowering people to monitor their health at home.
Why the Rare Disease Community?
Over 3.5 million people worldwide live with rare diseases, with around 40% experiencing haematological co-morbidities. Blood health plays a crucial role in diagnosing and managing rare conditions, but frequent trips to the lab for tests can add yet another burden to an already difficult healthcare journey. This presented an opportunity for Manfredi: if blood tells us so much about a person’s health, offering a portable, user-friendly blood test could provide life-changing benefits to people with rare diseases.
Beyond Blood’s journey into the rare disease space started when they joined the Cambridge Rare Disease Network’s RAREsummit23. It was here that they participated in the live Dragon’s Den-style Tech Solution Pitching Competition. Competing against other innovators, Beyond Blood won the audience vote thanks to the enthusiastic support from the rare disease community. This victory sparked a vital collaboration between the two, shaping the company’s understanding of how their technology could best serve this underserved population.
Co-designing the Future with the Rare Disease Community
Since RAREsummit23, Beyond Blood has worked closely with the rare disease community to refine its technology. With help from CamRARE, they conducted surveys, gathering insights directly from those living with rare conditions. This feedback has been invaluable in shaping their product, ensuring that it meets the unique needs of the people who will benefit from it most.
One of the rare disease advocates who contributed to Beyond Blood’s journey is Max Fisher, who lives with Ehlers-Danlos Syndrome and other complex health conditions. Max visited Beyond Blood’s London offices to share their lived experience, providing the team with a first-hand understanding of what life with a rare disease entails.
“It was immensely valuable for the team to hear Max’s story,” says Manfredi. “We gained not just an understanding of the challenges but also the resilience and innovation displayed by those living with rare diseases. Their drive to engage with us and help us improve our technology has been incredible.”
The collection of works provides an innovative means to help people outside the rare disease community understand more about what life can be like with a rare disease. There will also be an exciting opportunity to come and have a go!
Looking Ahead: Expanding the Scope of Innovation
Beyond Blood’s original focus was on providing a full blood count at home, but they’ve since expanded their vision. Their device now offers tests that provide more detailed insights into blood health, including monocyte and cell distribution counts. They’re even working towards integrating a C-reactive protein (CRP) test, which can offer valuable information about inflammation and infection.
To achieve this, Beyond Blood is collaborating with global companies working on similar microfluidic technologies, pushing the boundaries of what their device can do. These advances will benefit rare disease patients and have broader applications for viral infections and other health concerns. Their work has been recently featured on the Imperial College website, and they have received funding from the Canadian National Research Council for a joint project with the NRC’s Nanotechnology Research Centre to develop a circulating tumour cell isolation and detection point of care device.
And this is just the beginning. Beyond Blood’s ultimate dream is to develop a wearable or implantable device that continuously monitors a patient’s health without any intervention. This could be a game-changer for patients living with conditions such as Alzheimer’s, parents, or anyone who struggles with managing their healthcare.
“Working with the rare disease community has been eye-opening,” Manfredi reflects. “We’re just scratching the surface of the complexities involved, but the passion and knowledge of the people we’ve spoken to have been crucial in guiding our work.”
See Beyond Blood in Action at RAREfest24
Beyond Blood’s future is bright, and they’re eager to share their progress with the world. At RAREfest24, they’ll showcase their exciting prototype to the rare disease community. Attendees will have the chance to see the device in action and engage with the team about the next steps in their journey. Beyond Blood will also offer a sneak peek at Version 2 of their device, which is currently in development.
Beyond Blood is more than just a promising tech company—it’s a shining example of what can happen when innovators collaborate with the people they aim to serve. By working hand-in-hand with the rare disease community, they’ve created a product that has the potential to transform healthcare for millions of people. And this is only the start of their journey.
Be sure to stop by their booth at RAREfest24 and witness the future of healthcare in action. Beyond Blood’s story is one of innovation, collaboration, and hope—a journey that they’re excited to continue with the rare disease community at their side.




